Filing Details
- Accession Number:
- 0001562180-24-006767
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-09-11 16:00:27
- Reporting Period:
- 2024-09-09
- Accepted Time:
- 2024-09-11 16:00:27
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1822462 | Foghorn Therapeutics Inc. | FHTX | Pharmaceutical Preparations (2834) | 000000000 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1831749 | F. Steven Bellon | 500 Technology Square Ste 700 Cambridge MA 02139 | Chief Scientific Officer | No | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-09-09 | 20,000 | $9.50 | 101,957 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan that was adopted by the reporting person on March 11, 2024.
Billionaire Hedge Funds
